GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroTech Ltd (HKSE:02172) » Definitions » EV-to-FCF

MicroPort NeuroTech (HKSE:02172) EV-to-FCF : -74.28 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroTech EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, MicroPort NeuroTech's Enterprise Value is HK$3,966.8 Mil. MicroPort NeuroTech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-53.4 Mil. Therefore, MicroPort NeuroTech's EV-to-FCF for today is -74.28.

The historical rank and industry rank for MicroPort NeuroTech's EV-to-FCF or its related term are showing as below:

HKSE:02172' s EV-to-FCF Range Over the Past 10 Years
Min: -91.59   Med: 29.36   Max: 119.33
Current: -77.7

During the past 5 years, the highest EV-to-FCF of MicroPort NeuroTech was 119.33. The lowest was -91.59. And the median was 29.36.

HKSE:02172's EV-to-FCF is ranked worse than
100% of 360 companies
in the Medical Devices & Instruments industry
Industry Median: 27.515 vs HKSE:02172: -77.70

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), MicroPort NeuroTech's stock price is HK$8.59. MicroPort NeuroTech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.273. Therefore, MicroPort NeuroTech's PE Ratio for today is 31.47.


MicroPort NeuroTech EV-to-FCF Historical Data

The historical data trend for MicroPort NeuroTech's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroTech EV-to-FCF Chart

MicroPort NeuroTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - - 62.43 -114.28

MicroPort NeuroTech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial - - 62.43 - -114.28

Competitive Comparison of MicroPort NeuroTech's EV-to-FCF

For the Medical Devices subindustry, MicroPort NeuroTech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort NeuroTech's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroTech's EV-to-FCF falls into.



MicroPort NeuroTech EV-to-FCF Calculation

MicroPort NeuroTech's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3966.828/-53.404
=-74.28

MicroPort NeuroTech's current Enterprise Value is HK$3,966.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort NeuroTech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-53.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroTech  (HKSE:02172) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

MicroPort NeuroTech's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8.59/0.273
=31.47

MicroPort NeuroTech's share price for today is HK$8.59.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort NeuroTech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.273.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


MicroPort NeuroTech EV-to-FCF Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroTech's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroTech (HKSE:02172) Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Corporation
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroTech (HKSE:02172) Headlines

No Headlines